Hepatocellular carcinoma non-resectable

Clinical trials for Hepatocellular carcinoma non-resectable explained in plain language.

Never miss a new study

Get alerted when new Hepatocellular carcinoma non-resectable trials appear

Sign up with your email to follow new studies for Hepatocellular carcinoma non-resectable, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 7 Not yet recruiting 3 Not yet finished but already full! 3 Completed 1 Terminated 1

Can a triple attack shrink untreatable liver tumors?

Disease control Completed

This trial is testing whether combining a procedure that blocks blood flow to tumors (TACE) with two drugs—sintilimab, which boosts the immune system, and bevacizumab, which cuts off tumor blood supply—can safely and effectively treat liver cancer that cannot be surgically remove…

Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE

Phase 1 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Hepatocellular carcinoma non-resectable

Get alerted when new Hepatocellular carcinoma non-resectable trials appear

Can a triple attack shrink untreatable liver tumors?